There is increasing evidence that Residual Kidney Function (RKF) is a major contributor to long-term survival in both the Haemodialysis (HD) and Peritoneal Dialysis (PD) population. Dialysis strategies that protect RKF may therefore be beneficial. Both prospective and retrospective non-randomised studies have demonstrated that patients commencing twice-weekly haemodialysis have a slower rate of decline of RKF. Incremental dialysis uses the concept of individualising dialysis dose according to RKF. To determine whether in-centre incremental dialysis compared to standard 3 times weekly haemodialysis preserves RKF would require a major randomised controlled trial. A pilot feasibility study needs to be conducted to answer some key questions to inform the design of the definitive RCT. This pilot feasibility study will be conducted in 4 centres. Fifty patients will be randomised (1:1) to either conventional 3 times weekly HD or an incremental HD protocol and will be followed up for 12 months after randomisation.
|Short title||Incremental Dialysis Study|
|Effective start/end date||6/03/18 → 31/08/20|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.